Epidermal growth factor receptor mutations in non-small cell lung cancer: Predicting clinical response to kinase inhibitors

被引：19
|
作者：
Sequist, LV [1 ]
Haber, DA [1 ]
Lynch, TJ [1 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 16期
关键词：
D O I：
10.1158/1078-0432.CCR-05-1055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5668 / 5670
页数：3
相关论文
共 50 条
  • [41] Effectiveness Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors On Non-Small Cell Lung Cancer Harboring Rare EGFR Mutations
    Chang, L. -C.
    Chen, K. -Y.
    Shih, J. -Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [42] The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
    Belloni, Alessia
    Pugnaloni, Armanda
    Rippo, Maria Rita
    Di Valerio, Silvia
    Giordani, Chiara
    Procopio, Antonio Domenico
    Bronte, Giuseppe
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 194
  • [43] Epidermal growth factor receptor in non-small cell lung cancer
    Prabhakar, Charles N.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 110 - 118
  • [44] An update on the role of epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Edelman, MJ
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S3 - S8
  • [45] Influence of aromatase and epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Kritikou, I.
    Giannopoulou, E.
    Koutras, A. K.
    Kalofonos, H. P.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 553 - 553
  • [46] Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer
    Heymach, John V.
    Nilsson, Monique
    Blumenschein, George
    Papadimitrakopoulou, Vassiliki
    Herbst, Roy
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4441S - 4445S
  • [47] Correlation of the epidermal growth factor mutations in non-small cell lung cancer with response to erlotinib
    Park, Sarah
    Ahn, Myung-Ju
    Ahn, Jin Seok
    Kim, Sang We
    Kim, Heung-Tae
    Lee, Jong Seog
    Kang, Jin Hyung
    Cho, Jae Yong
    Song, Hong Suk
    Park, Se Hoon
    Shin, Sang Won
    Choi, Jin Hyuck
    Park, Keunchil
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 251 - 251
  • [48] Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Sequist, Lecia V.
    [J]. ONCOLOGIST, 2007, 12 (03): : 325 - 330
  • [49] Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Engelman, Jeffrey A.
    Jaenne, Pasi A.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (10) : 2895 - 2899
  • [50] Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
    Gao, Yuan
    Song, PingPing
    Li, Hui
    Guo, HongBo
    Jia, Hui
    Zhang, BaiJiang
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 13 - 20
12345